-
Part 2 | Session 7 Plenary session 9 – New technologies for HF management
-
Part 2 | Session 8 Plenary session 10 – Special Populations
-
Part 1 | Session 1 Plenary session 1 – Recent guideline updates in HF
-
Part 1 | Session 3 Plenary session 2 – GDMT in the clinical setting
-
Part 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM
-
Part 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice
-
Part 1 | Session 8 Plenary session 4 – Obesity and weight management in HF
-
Part 1 | Session 10 Plenary session 5 – Worsening and acute heart failure
-
Part 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence
-
Part 2 | Session 4 Plenary session 7 – Managing comorbidities in HF
-
Part 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Stefan Anker
Professor of Cardiology
Prof Stefan D Anker is a German cardiologist born in Berlin, Germany. He studied medicine at Charité Medical School of Humboldt University Berlin, where he completed his medical degree in 1993. He later pursued research training at the National Heart & Lung Institute, Imperial College London, completing his PhD in 1998. Following his return to Germany, Prof Anker held academic and research positions at Charité Berlin and later at University Medical Center Göttingen before returning to Charité in 2017 to serve as Professor of (Tissue) Homeostasis in Cardiology & Metabolism. His work has taken him across multiple institutions and countries through long-standing international collaborations.
Academic History
Prof Anker began his medical education at Charité Medical School, graduating in 1993. He then continued postgraduate academic training in both Germany and the United Kingdom, completing his PhD at the National Heart & Lung Institute in London…
Javed Butler
Professor of Medicine
Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.
He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.
Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.
Klaus Witte
Klaus Witte is a Cardiologist at the Leeds Institute of Cardiovascular & Metabolic Medicine, Leeds, UK, where his research group focuses on patient-orientated questions with a commitment to enhancing efficacy through the personalised application of new and existing therapies in chronic heart failure (CHF).
Challenging conventional teaching around heart rate and exercise capacity in CHF, Dr Witte’s group has developed a reliable method to map the force-frequency relationship in CHF. Through this approach, they have demonstrated improvements in exercise capacity in patients with CHF and pacemakers (JACC-HF 2018, Circulation 2020). His earlier work also questioned established doctrines in this field (JACC 2016).
Looking ahead, Dr Witte is keen to address pressing challenges, including the escalating issue of health economics across Europe, the adaptation of care pathways, and the need to convey the increasingly complex molecular basis of clinical syndromes to…
Comments